chr15-88854874-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1
The NM_001369268.1(ACAN):c.2289C>T(p.Pro763Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.588 in 1,494,474 control chromosomes in the GnomAD database, including 270,953 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.48 ( 20173 hom., cov: 33)
Exomes 𝑓: 0.60 ( 250780 hom. )
Consequence
ACAN
NM_001369268.1 synonymous
NM_001369268.1 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.817
Genes affected
ACAN (HGNC:319): (aggrecan) This gene is a member of the aggrecan/versican proteoglycan family. The encoded protein is an integral part of the extracellular matrix in cartilagenous tissue and it withstands compression in cartilage. Mutations in this gene may be involved in skeletal dysplasia and spinal degeneration. Multiple alternatively spliced transcript variants that encode different protein isoforms have been observed in this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.41).
BP6
Variant 15-88854874-C-T is Benign according to our data. Variant chr15-88854874-C-T is described in ClinVar as [Benign]. Clinvar id is 1181962.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr15-88854874-C-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.817 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.638 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ACAN | NM_001369268.1 | c.2289C>T | p.Pro763Pro | synonymous_variant | 12/19 | ENST00000560601.4 | NP_001356197.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ACAN | ENST00000560601.4 | c.2289C>T | p.Pro763Pro | synonymous_variant | 12/19 | 3 | NM_001369268.1 | ENSP00000453581.2 |
Frequencies
GnomAD3 genomes AF: 0.483 AC: 73335AN: 151986Hom.: 20175 Cov.: 33
GnomAD3 genomes
AF:
AC:
73335
AN:
151986
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.504 AC: 80915AN: 160402Hom.: 22906 AF XY: 0.519 AC XY: 44677AN XY: 86082
GnomAD3 exomes
AF:
AC:
80915
AN:
160402
Hom.:
AF XY:
AC XY:
44677
AN XY:
86082
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.600 AC: 805043AN: 1342370Hom.: 250780 Cov.: 53 AF XY: 0.597 AC XY: 392611AN XY: 657470
GnomAD4 exome
AF:
AC:
805043
AN:
1342370
Hom.:
Cov.:
53
AF XY:
AC XY:
392611
AN XY:
657470
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.482 AC: 73330AN: 152104Hom.: 20173 Cov.: 33 AF XY: 0.475 AC XY: 35305AN XY: 74366
GnomAD4 genome
AF:
AC:
73330
AN:
152104
Hom.:
Cov.:
33
AF XY:
AC XY:
35305
AN XY:
74366
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1158
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 05, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Spondyloepimetaphyseal dysplasia, aggrecan type Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 14, 2021 | - - |
Osteochondritis dissecans Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 14, 2021 | - - |
Spondyloepiphyseal dysplasia, Kimberley type Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 14, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at